(Q43102438)

English

Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice

scientific article published on 12 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

cognitive dysfunction

1 reference

based on heuristic

inferred from title

author name string

Xiaoli Pan

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Neng Gong

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Jing Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Zhe Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Fenghua Gu

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Jia Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Xiaojing Sun

7

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Lei Zhao

8

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Meijing Yu

9

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Zhiru Xu

10

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Wenxin Dong

11

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Yan Qin

12

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Guoqiang Fei

13

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Chunjiu Zhong

14

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Tian-Le Xu

15

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

language of work or name

0 references

publication date

12 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

133

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Pt 5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

1342-1351

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Inhibition of acetylcholinesterase by thiamine. A structure-function study

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Thiamine and Alzheimer's disease. A pilot study

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Thiamine-dependent processes and treatment strategies in neurodegeneration

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Positron emission tomography imaging in dementia.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Rapid HPLC measurement of thiamine and its phosphate esters in whole blood

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Thiamine therapy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

A trial of thiamine in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Thiamine tetrahydrofurfuryl disulfide improves energy metabolism and physical performance during physical-fatigue loading in rats

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Decreased transketolase activity contributes to impaired hippocampal neurogenesis induced by thiamine deficiency

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ069

21 January 2018

Identifiers

10.1093/BRAIN/AWQ069

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43102438&oldid=1980840906"